Baclofen and Electrocardiogram st segment abnormal - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st segment abnormal is reported as a side effect among people who take Baclofen (baclofen), especially for people who are female, 60+ old, also take Diclofenac, and have Glioma.

The phase IV clinical study analyzes which people have Electrocardiogram st segment abnormal when taking Baclofen. It is created by eHealthMe based on reports of 106,082 people who have side effects when taking Baclofen from the FDA, and is updated regularly.

What is Baclofen?

Baclofen has active ingredients of baclofen. It is often used in muscle spasms. eHealthMe is studying from 108,662 Baclofen users. Check the latest studies of Baclofen.

What is Electrocardiogram st segment abnormal?

Electrocardiogram st segment abnormal is found to be associated with 285 drugs and 452 conditions by eHealthMe. Check the latest studies of Electrocardiogram st segment abnormal.

On Jul, 12, 2026

106,082 people reported to have side effects when taking Baclofen.
Among them, 28 people (0.03%) have Electrocardiogram st segment abnormal.

Could Baclofen cause Electrocardiogram st segment abnormal?

Among these 28 people:

What is the gender of people who have Electrocardiogram st segment abnormal when taking Baclofen? *

female: 72 %
male: 28 %

What is the age of people who have Electrocardiogram st segment abnormal when taking Baclofen? *

What are other drugs people take besides Baclofen? *

What are other side effects people have besides Electrocardiogram st segment abnormal? *

Nausea And Vomiting: 16 people, 57.14%
Nausea (feeling of having an urge to vomit): 14 people, 50.00%
Fatigue (feeling of tiredness): 11 people, 39.29%
Malaise (a feeling of general discomfort or uneasiness): 11 people, 39.29%
Abdominal Pain: 11 people, 39.29%
Tremor (trembling or shaking movements in one or more parts of your body): 10 people, 35.71%
Arrhythmias (irregular heartbeat): 10 people, 35.71%
Influenza Like Illness: 10 people, 35.71%
Hypokalemia (low potassium): 10 people, 35.71%
Diarrhea: 10 people, 35.71%

What are the existing conditions these people have? *

Glioma (a type of tumour that starts in the brain or spine): 8 people, 28.57%
Pain: 7 people, 25.00%
Abdominal Pain Upper: 6 people, 21.43%
Oedema (fluid collection in tissue): 6 people, 21.43%
Muscle Aches (muscle pain): 6 people, 21.43%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 6 people, 21.43%
Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 17.86%
Haemorrhage (bleeding): 2 people, 7.14%
Thyroiditis (inflammation of thyroid gland): 2 people, 7.14%
Depression: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Baclofen and have Electrocardiogram st segment abnormal?

- Check whether Electrocardiogram st segment abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Baclofen:

Baclofen (108,662 reports)

Browse all side effects of Baclofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Electrocardiogram st segment abnormal:

Electrocardiogram st segment abnormal (285 drugs)

Browse all the conditions that are associated with Electrocardiogram st segment abnormal:

Electrocardiogram st segment abnormal (452 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on baclofen (the active ingredients of Baclofen) and Baclofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.